CJEU, C-673/18: no supplementary protection certificate for a new therapeutic application of an active ingredient which has already been the subject of a previous marketing authorisation

The Court of Justice ruled that a second Supplementary Protection Certificate (SPC) cannot be granted, in case of a drug whose active ingredients are already covered by a previous marketing authorisation (MA), no matter if the (second) MA concerns a new therapeutic indication.

DOWNLOAD PDF